Daily non-political popular news in brief.

A new pharmaceutical drug that halts progress of metastatic kidney cancer

03-01-2007 · EurekAlert!

Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.

Keywords: pharmaceutical, drug, halts, progress, metastatic, kidney, cancer, halt

« Previous | Next »

Similar news on "A new pharmaceutical drug that halts progress of metastatic kidney cancer":

Other highlights in the Jan. 8 JNCI
01-08-2008 · EurekAlert!
Also in the Jan. 8 JNCI are an association between statin use and reduced cancer risk, a potential colon cancer drug target, a mouse model for studying kidney cancer, and a review of how tumor viruses regulate telomeres.
Similar news · Read more »
Kidney cancer drug attacks a major type of acute myeloid leukemia
01-29-2008 · EurekAlert!
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia, the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
Similar news · Read more »
Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
11-08-2006 · EurekAlert!
One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action, the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague was told on Wednesday.
Similar news · Read more »
Tailored treatments: Promising designer drug provides new insight into cancer biology
11-13-2006 · EurekAlert!
Scientists are making progress toward unraveling the molecular mysteries that underlie cancer progression and treatment resistance. Two studies in the November 2006 issue of the journal Cancer Cell, published by Cell Press, provide mechanistic details that may explain why the small-molecule chemical ABT-737 is emerging as a unique and effective anticancer agent.
Similar news · Read more »
Synthetic peptide targets latent papilloma virus infections
01-02-2007 · EurekAlert!
Infection with the human papilloma virus, the major cause of cervical cancer, is forever. The virus remains latent in skin cells, ready to flare up at any time to create warts on the skin or the genitals. A new finding by UC Berkeley's Michael Botchan and colleagues offers hope that a drug can halt spread of the virus into new cells, and perhaps even eliminate the virus from the body.
Similar news · Read more »
Drug industry increasingly influences breast cancer research
02-26-2007 · EurekAlert!
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Similar news · Read more »
Drug combination effective against multiple myeloma, researchers show
11-21-2007 · EurekAlert!
Pairing a new thalidomide derivative with a steroid slows progress of multiple myeloma, an incurable bone marrow cancer, and prolongs the lives of patients who have relapsed from previous treatment, researchers report in the Nov. 22 New England Journal of Medicine.
Similar news · Read more »
Sutent achieves first line EAU approval for kidney cancer
03-22-2007 · EurekAlert!
Sutent (sunitinib malate) has received a European Association of Urology recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma.
Similar news · Read more »
Latest drugs improve survival for metastatic breast cancer
07-23-2007 · EurekAlert!
Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.
Similar news · Read more »
Kidney Progress: Drug slows cyst growth
11-25-2006 · Science News Online
The trial drug roscovitine has been shown to reverse polycystic kidney disease in mice.
Similar news · Read more »